Evidence map›Paper›PMID 42261239›Full record

ArticleJournal of child and adolescent psychopharmacology2026

Context Matters: Variation in Pharmacologic Management of Pediatric Agitation Across Emergency and Inpatient Psychiatric Settings.

Sean T Lynch, Angelo I Chaia, Ricky Burns, Chaden Noureddine, Timothy R Rice, Ashley N Sterchele

Abstract read
In one paragraph

Article in Journal of child and adolescent psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sean T LynchDivision on Substance Use Disorders, Vagelos College of Physicians and Surgeons, New York State Psychiatric Institute, Columbia University, New York, NY, USA.ORCID 0000-0001-9092-8491
Angelo I ChaiaDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, Mount Sinai Behavioral Health Center, New York, NY, USA.ORCID 0000-0002-5952-6571
Ricky BurnsDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, Mount Sinai Behavioral Health Center, New York, NY, USA.
Chaden NoureddineDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, Mount Sinai Behavioral Health Center, New York, NY, USA.
Timothy R RiceDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, Mount Sinai Morningside-West, New York, NY, USA.
Ashley N StercheleDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, Mount Sinai Behavioral Health Center, New York, NY, USA.

Funding

Translational Clinical Research Fellowship on Substance Use DisordersT32DA007294 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Frances Rudnick Levin, Diana M Martinez · 1993 to 2026
$9.3M
NIDA NIH HHS T32 DA007294
6 · The paper itself

Abstract

backgroundManagement of acute agitation in youth frequently involves intramuscular (IM) antipsychotics; however, little is known about how treatment strategies vary across care settings. Differences between emergency and inpatient psychiatric environments may influence medication selection and dosing.

methodsThis retrospective secondary analysis included youth (<18 years) who received IM antipsychotics for agitation across multiple emergency departments and inpatient psychiatric units within a large urban health system (2019-2023). Comparisons between settings examined antipsychotic selection, coadministration of adjunctive medications, and dosing. To account for differences in medication selection, dosing comparisons were conducted within each antipsychotic agent. Secondary outcomes included repeat IM administration and restraint or seclusion within 24 hours.

resultsThe sample included 158 youth (86 emergency, 72 inpatient). Antipsychotic selection differed significantly by setting, with greater use of haloperidol in emergency settings and chlorpromazine in inpatient settings (

conclusionsPharmacologic management of pediatric agitation varies by care setting, particularly in antipsychotic selection and adjunctive medication use. Differences in dosing were limited to chlorpromazine, suggesting that variation reflects agent-specific prescribing patterns rather than overall treatment intensity. These findings highlight the influence of clinical context and provider practice patterns in shaping management strategies for pediatric agitation.

Indexed as

Antipsychotic AgentsEmergency Service, HospitalPsychomotor AgitationAdolescentChildFemaleHaloperidolHumansInjections, IntramuscularInpatientsMaleRetrospective StudiesAntipsychotic AgentsHaloperidolemergency psychiatryinpatient psychiatryintramuscular antipsychoticspediatric agitationpractice patterns

Identifiers

PMID42261239
PMCPMC13515422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.